Cargando…
S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428326/ http://dx.doi.org/10.1097/01.HS9.0000967576.33522.1a |
| _version_ | 1785090441663741952 |
|---|---|
| author | Giagounidis, Aristoteles Cluzeau, Thomas Díez Campelo, María Ross, David Chee, Lynette Tan, Shuhying Graham, Christine Feng, Wei Yang, Ming Jiang, Ying Ross, Miranda Mcginty, Allie Bobba, Suresh Rovaldi, Christopher Cooper, Simon Salstrom, Jen |
| author_facet | Giagounidis, Aristoteles Cluzeau, Thomas Díez Campelo, María Ross, David Chee, Lynette Tan, Shuhying Graham, Christine Feng, Wei Yang, Ming Jiang, Ying Ross, Miranda Mcginty, Allie Bobba, Suresh Rovaldi, Christopher Cooper, Simon Salstrom, Jen |
| author_sort | Giagounidis, Aristoteles |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428326 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283262023-08-17 S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION Giagounidis, Aristoteles Cluzeau, Thomas Díez Campelo, María Ross, David Chee, Lynette Tan, Shuhying Graham, Christine Feng, Wei Yang, Ming Jiang, Ying Ross, Miranda Mcginty, Allie Bobba, Suresh Rovaldi, Christopher Cooper, Simon Salstrom, Jen Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428326/ http://dx.doi.org/10.1097/01.HS9.0000967576.33522.1a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Giagounidis, Aristoteles Cluzeau, Thomas Díez Campelo, María Ross, David Chee, Lynette Tan, Shuhying Graham, Christine Feng, Wei Yang, Ming Jiang, Ying Ross, Miranda Mcginty, Allie Bobba, Suresh Rovaldi, Christopher Cooper, Simon Salstrom, Jen S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title | S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title_full | S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title_fullStr | S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title_full_unstemmed | S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title_short | S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION |
| title_sort | s166: ker-050 treatment improved markers of erythropoietic activity and hematopoiesis over six months which resulted in hematological responses across a broad, lower-risk mds population |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428326/ http://dx.doi.org/10.1097/01.HS9.0000967576.33522.1a |
| work_keys_str_mv | AT giagounidisaristoteles s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT cluzeauthomas s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT diezcampelomaria s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT rossdavid s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT cheelynette s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT tanshuhying s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT grahamchristine s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT fengwei s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT yangming s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT jiangying s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT rossmiranda s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT mcgintyallie s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT bobbasuresh s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT rovaldichristopher s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT coopersimon s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation AT salstromjen s166ker050treatmentimprovedmarkersoferythropoieticactivityandhematopoiesisoversixmonthswhichresultedinhematologicalresponsesacrossabroadlowerriskmdspopulation |